Mitoxantrone Hydrochloride Liposome Combined With Capecitabine in Patients With HER-2 Negative Advanced Breast Cancer

NCT06156761 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Mitoxantrone hydrochloride liposome
DRUG: Capecitabine
DRUG: Mitoxantrone hydrochloride liposome
DRUG: Capecitabine

Sponsor

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Collaborators

[object Object]